| __timestamp | Amneal Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 31354781 |
| Thursday, January 1, 2015 | 136870000 | 43445817 |
| Friday, January 1, 2016 | 204747000 | 66489820 |
| Sunday, January 1, 2017 | 191938000 | 96886134 |
| Monday, January 1, 2018 | 210451000 | 153793000 |
| Tuesday, January 1, 2019 | 202287000 | 148369000 |
| Wednesday, January 1, 2020 | 190585000 | 151934000 |
| Friday, January 1, 2021 | 209563000 | 198532000 |
| Saturday, January 1, 2022 | 200046000 | 112128000 |
| Sunday, January 1, 2023 | 167778000 | 76192000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Amneal Pharmaceuticals, Inc. and TG Therapeutics, Inc. have shown distinct strategies in their research and development (R&D) investments. From 2014 to 2023, Amneal consistently outpaced TG Therapeutics, investing approximately 70% more in R&D on average. Notably, in 2018, Amneal's R&D expenses peaked, reaching nearly double that of TG Therapeutics. However, TG Therapeutics demonstrated a remarkable growth trajectory, increasing its R&D spending by over 500% from 2014 to 2021. This surge highlights TG Therapeutics' commitment to innovation, despite its smaller scale. As the pharmaceutical landscape evolves, these investment patterns may shape the future breakthroughs and market positions of these companies. Understanding these trends offers valuable insights into the strategic priorities driving the pharmaceutical industry today.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.